XML 33 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Shareholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2017
Option Indexed to Issuer's Equity [Line Items]  
Schedule of stock warrants
     Weighted 
     Average 
     Exercise 
  Number  Price 
Outstanding at beginning of the period  10,576,389  $0.08 
Granted during the period  7,500,000  $0.41 
Exercised during the period  ---  $--- 
Terminated during the period  ---  $--- 
Outstanding at end of the period  18,076,389  $0.22 
         
Exercisable at end of the period  18,076,389  $0.22 
         
Weighted average remaining life  4.9 years     
Summary of shares issued and outstanding under the EIP outstanding
Outstanding at beginning of the period  1,552,500 
Granted during the period  --- 
Terminated during the period  (85,000)
Outstanding at end of the period  1,467,500 
     
Shares vested at period-end  807,500 
Weighted average grant date fair value of shares granted during the period $--- 
Aggregate grant date fair value of shares granted during the period $--- 
Shares available for grant pursuant to EIP at period-end  11,686,184 
Schedule of stock options outstanding

 
2017  2016 
  Number  Weighted Average Exercise
Price
  Number  Weighted Average Exercise
Price
 
Outstanding at beginning of the period  2,349,996  $0.12   ---  $--- 
Granted during the period  ---  $---   ---  $--- 
Exercised during the period  ---  $---   ---  $--- 
Terminated during the period  ---  $---   ---  $--- 
Outstanding at end of the period  2,349,996  $0.12   ---  $--- 
                 
Options exercisable at period-end  100,000       ---     
Weighted average remaining life (in years)  9.4       ---     
Weighted average grant date fair value of options granted during the period $---       ---     
Options available for grant at period-end  11,601,184       13,988,680     
Warrant [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Schedule of stock warrants outstanding
Warrants Outstanding  Warrants Exercisable 
      Weighted-          
      Average  Weighted-     Weighted- 
      Remaining  Average     Average 
Exercise  Number  Contractual  Exercise  Number  Exercise 
Prices  Outstanding  Life (years)  Price  Exercisable  Price 
$0.05 to 0.09   8,388,889   5.1  $0.08   8,388,889  $0.08 
$0.10 to 0.15   2,687,500   4.4  $0.11   2,687,500  $0.11 
$0.25   4,000,000   5.0  $0.25   4,000,000  $0.25 
$0.50   2,000,000   5.0  $0.50   2,000,000  $0.50 
$1.00   1,000,000   5.0  $1.00   1,000,000  $1.00 
$0.05 to 1.00   18,076,389   4.9  $0.22   18,076,389  $0.22 
Employee Stock Options [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Schedule of stock warrants outstanding
Options Outstanding  Options Exercisable 
      Weighted-          
      Average   Weighted-        Weighted- 
      Remaining   Average        Average 
 Exercise    Number  Contractual   Exercise    Number   Exercise 
 Prices    Outstanding  Life (years)   Price    Exercisable   Price 
$0.08   1,600,000   9.3  $0.08   100,000  $0.08 
$0.20   749,996   9.7  $0.20   ---  $--- 
$0.08 to 0.20     2,349,996   9.4  $0.12   100,000  $0.08 
Summary of nonvested shares issued
     Weighted 
     Average 
     Exercise 
  Number  Price 
Outstanding at beginning of the period  2,349,996  $0.12 
Granted during the period  ---  $--- 
Exercised during the period  ---  $--- 
Terminated during the period  ---  $--- 
Outstanding at end of the period  2,349,996  $0.12 
         
Options exercisable at period-end  100,000     
Weighted average remaining life (in years)  9.4     
Weighted average grant date fair value of options granted during the period $---     
Options available for grant at period-end  11,601,184     
Employee Equity Incentive Plan [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Summary of nonvested shares issued
     Weighted 
     Average 
     Grant Date 
  Shares  Fair Value 
Nonvested at January 1, 2017  940,000  $0.04 
Granted  ---  $--- 
Vested  (207,500) $0.04 
Forfeited  (85,000) $0.04 
Nonvested at March 31, 2017  647,500  $0.04